7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1-3-dimethylxanthine and Myocardial-Infarction

7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1-3-dimethylxanthine has been researched along with Myocardial-Infarction* in 1 studies

Other Studies

1 other study(ies) available for 7-(2-(4-(4-nitrobenzene)piperazinyl)ethyl)-1-3-dimethylxanthine and Myocardial-Infarction

ArticleYear
KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP-9/TIMP-1 balance.
    British journal of pharmacology, 2011, Volume: 162, Issue:1

    Previously, 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) has been shown to induce aortic smooth muscle relaxation through K(ATP) channel opening and endothelial nitric oxide synthase (eNOS) enhancement. We further investigated whether KMUP-3 protects against myocardial remodelling after myocardial infarction (MI), and whether KMUP-3 increases the expression of eNOS in MI rats.. Wistar rats were randomly allocated into three groups: MI (n= 10), MI + KMUP-3 group (n= 10) and sham group (n= 10). MI was induced by ligation of the left anterior descending coronary artery. After recovery, the MI + KMUP-3 group received KMUP-3 (0.3 mg·kg(-1) ·day(-1) ) infusion for 4 weeks, while the MI and sham group received vehicle only. To further confirm that the effect of KMUP-3 is dependent on eNOS, KMUP-3 was applied in the culture of transforming growth factor-β-stimulated human cardiac fibroblasts.. KMUP-3 treatment attenuated cardiac hypertrophy post-MI and improved cardiac function. The fibrotic area was reduced by KMUP-3 both in central-, peri- and non-infarction areas. KMUP-3 enhanced the expression of eNOS and tissue inhibitor of metalloproteinase-1 (TIMP-1), but reduced matrix metalloproteinase-9 (MMP-9) expression. In vitro, the activities of KMUP-3 were blocked by pretreatment with the eNOS inhibitor N(ω) -nitro-L-arginine methyl ester.. The K(ATP) channel opener KMUP-3 preserved cardiac function after MI by enhancing the expression of eNOS. In addition, KMUP-3 restored the myocardial MMP-9/TIMP-1 balance and attenuated ventricular remodelling by an eNOS-dependent mechanism.

    Topics: Animals; Blotting, Western; Cells, Cultured; Hemodynamics; Humans; Male; Matrix Metalloproteinase 9; Myocardial Infarction; Nitric Oxide Synthase Type III; Piperidines; Rats; Rats, Wistar; Tissue Inhibitor of Metalloproteinase-1; Ventricular Remodeling; Xanthines

2011